Modica, R.; Minotta, R.; Liccardi, A.; Cannavale, G.; Benevento, E.; Colao, A.
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC). J. Pers. Med. 2023, 13, 953.
https://doi.org/10.3390/jpm13060953
AMA Style
Modica R, Minotta R, Liccardi A, Cannavale G, Benevento E, Colao A.
Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC). Journal of Personalized Medicine. 2023; 13(6):953.
https://doi.org/10.3390/jpm13060953
Chicago/Turabian Style
Modica, Roberta, Roberto Minotta, Alessia Liccardi, Giuseppe Cannavale, Elio Benevento, and Annamaria Colao.
2023. "Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)" Journal of Personalized Medicine 13, no. 6: 953.
https://doi.org/10.3390/jpm13060953
APA Style
Modica, R., Minotta, R., Liccardi, A., Cannavale, G., Benevento, E., & Colao, A.
(2023). Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC). Journal of Personalized Medicine, 13(6), 953.
https://doi.org/10.3390/jpm13060953
